Related Experiment Video
Updated: Apr 15, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
11.1K
Simultaneous inference of a misclassified outcome and competing risks failure time data
1Division of Biostatistics, The University of Texas Health Science Center at Houston, 1200 Pressler St, Houston, TX 77030, USA ( sheng.t.luo@uth.tmc.edu ;
Journal of Applied Statistics
|March 31, 2015
Summary
This study introduces a new statistical framework to accurately classify ipsilateral breast tumor relapse (IBTR) in breast cancer patients. It addresses misclassification and competing risks for better understanding treatment outcomes.
Area of Science:
- Oncology
- Biostatistics
- Medical Informatics
Background:
- Ipsilateral breast tumor relapse (IBTR) is a common concern for breast cancer patients undergoing breast conservation therapy.
- Accurate classification of IBTR (true recurrence vs. new primary tumor) is challenging due to lack of a gold standard, impacting treatment evaluation and survival analysis.
- Competing risks, such as death from breast cancer or other causes, can be correlated with IBTR status and time, complicating analysis.
Purpose of the Study:
- To propose a unified statistical framework for simultaneously modeling misclassified IBTR status and time to IBTR.
- To account for dependent competing terminal events in the analysis of breast cancer relapse.
- To provide a robust method for analyzing complex outcomes in oncology research.
Main Methods:
- Development of a unified statistical model to handle misclassified binary outcomes without a gold standard.
- Incorporation of correlated time to IBTR with dependent competing risks.
- Evaluation of the proposed framework through simulation studies and application to a real-world dataset of 4,477 breast cancer patients.
- Utilizing adaptive Gaussian quadrature tools within SAS procedure NLMIXED for model fitting.
Main Results:
- The proposed framework effectively addresses the challenges of misclassification and competing risks in IBTR analysis.
- Demonstrated the utility of the model in a large cohort of breast cancer patients, providing insights into relapse patterns.
- The model's flexibility allows for accurate estimation of relapse probabilities and survival outcomes.
Conclusions:
- The developed unified framework offers a powerful tool for accurately analyzing ipsilateral breast tumor relapse in breast cancer.
- This approach improves the understanding of true local recurrence versus new primary tumors, crucial for personalized treatment strategies.
- The model is expected to have broad applications in similar research settings involving complex survival data with misclassification and competing risks.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
725
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
725
01:15Assumptions of Survival Analysis
495
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
495
01:24Kaplan-Meier Approach
766
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
766
01:09Censoring Survival Data
687
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
687
01:11Hazard Rate
520
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
520
01:18Introduction To Survival Analysis
994
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
994